Effect of low level laser therapy on pain and quality of life in diabetic peripheral neuropathy

Physiotherapy ◽  
2015 ◽  
Vol 101 ◽  
pp. e495-e496 ◽  
Author(s):  
A.M. Gundmi
Keyword(s):  
Quality Of Life ◽  
Peripheral Neuropathy ◽  
Laser Therapy ◽  
Diabetic Peripheral Neuropathy ◽  
Low Level Laser Therapy ◽  
Low Level ◽  
Low Level Laser ◽  
Level Laser

scholarly journals Preliminary clinical experience of low-level laser therapy for the treatment of canine osteoarthritis-associated pain: A retrospective investigation on 17 dogs

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Loris Barale ◽  
Paolo Monticelli ◽  
Massimo Raviola ◽  
Chiara Adami
Keyword(s):  
Quality Of Life ◽  
Chronic Pain ◽  
Laser Therapy ◽  
Low Level Laser Therapy ◽  
Total Period ◽  
Low Level ◽  
Low Level Laser ◽  
Level Laser ◽  
Canine Osteoarthritis

Background: Osteoarthritis (OA) is common in dogs and causes chronic pain that affects the quality of life and may not respond to analgesics.Objective: The objective of this study was to determine whether low-level laser therapy (LLLT) would improve the quality of life and help reducing systemic analgesics, in dogs with OA.Methods: Seventeen client-owned dogs diagnosed with OA and associated pain were included. The diagnosis of OA was confirmed by orthopedic and radiographic examination. Pain was evaluated in each dog with the canine brief pain inventory (CBPI), compiled by the dog owners, as well as with a visual analog scale (VAS) and the colorado state canine chronic pain scale, used by the clinician. The LLLT was performed weekly in each study dog, for a total period of 6 weeks. The CBPI was then repeated at 2, 4, 6, and 8 weeks after the first laser session, whereas the VAS was reassessed at weeks 2 and 6. The dogs were observed for the occurrence of laser-related side effects.Results: Both CBPI and VAS were significantly reduced after the first laser session (9.2 ± 3.8 and 5.2 ± 1.1, respectively) compared to pretreatment values (11.8 ± 3.6 and 7.6 ± 0.9, respectively; and p = 0.018 and p < 0.001, respectively) and continued to decrease over time until the end of the therapy. Based on these results and improved function, as assessed by the orthopedic surgeon, the pharmacological analgesic therapy was reduced by the clinician at week 2 in 13 of 17 dogs. Laser-related side effects were not observed.Conclusion: This retrospective report provides a basis for future investigations, needed to clarify whether laser therapy may be beneficial to treat canine OA-associated pain. The preliminary findings are promising and suggest that LLLT may help reducing the analgesic administration and improving client satisfaction and the quality of life of dogs with OA. Keywords: Canine osteoarthritis, Chronic pain, Low-intensity laser therapy, Orthopedic pain.

scholarly journals Efficacy of low level laser therapy on painful diabetic peripheral neuropathy

LASER THERAPY ◽  
2015 ◽  
Vol 24 (3) ◽  
pp. 195-200 ◽  
Author(s):  
Shashi Kumar C G ◽  
Arun G Maiya ◽  
H Manjunath Hande ◽  
Sudha Vidyasagar ◽  
Karthik Rao ◽  
...  
Keyword(s):  
Peripheral Neuropathy ◽  
Laser Therapy ◽  
Diabetic Peripheral Neuropathy ◽  
Low Level Laser Therapy ◽  
Low Level ◽  
Low Level Laser ◽  
Painful Diabetic Peripheral Neuropathy ◽  
Level Laser

scholarly journals The effect of low-level laser therapy on quality of life in postmastectomy lymphedema patients

2020 ◽  
Vol 7 (9) ◽  
pp. 3971-3976
Author(s):  
Türkan Turgay ◽  
Tuba Denkçeken
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Laser Therapy ◽  
Life Assessment ◽  
Low Level Laser Therapy ◽  
Cancer Type ◽  
Low Level ◽  
Low Level Laser ◽  
Level Laser

Introduction: In this study, the aim was to evaluate the effect of low-level laser therapy (LLLT) on quality of life in postmastectomy lymphedema (PML) patients. Methods: Twenty-four female patients diagnosed with PML were included in the study. Demographic features, disease and lymphedema duration, cancer type, cancer stage, operation type, radiotherapy and chemotherapy history, lymphedematous and dominant extremity, and body mass index (BMI) were recorded. LLLT was applied to the affected limb as 904 nm, 1.5 Joule/cm2, three days a week for a total of 8 weeks. Quality of life assessment, lymphedema severity, and lymphedema staging was performed to measure effectiveness before and after treatment. Patients with lymphedema not associated with breast cancer and/or primary lymphedema, ongoing radiotherapy, metastatic high-grade breast cancer, acute infection, and deep vein thrombosis were excluded from the study. Results: Modified radical mastectomy was reported in 18 patients; total mastectomy and sentinel lymph node biopsy were reported in 6 patients. Of the patients, 45.8% were stage 3, and 54.2% were stage 2. Of the patients, 95.8% had a history of chemotherapy and 83% of radiotherapy after surgery. In this study, following LLLT, improvement of lymphedema stage and severity were found to be statistically significant (p < 0.05). In the evaluation of lymphedema quality of life, there was a statistically significant improvement in parameters including function, appearance, clinical symptoms, and overall quality of life (p < 0.05). However, no improvement was observed in the emotional state parameter (p > 0.05).  Conclusion: Thus, LLLT is a safe treatment method that increases the quality of life in breast cancerrelated lymphedema patients.

Sign in / Sign up

Export Citation Format

Share Document